12:00 AM
Oct 27, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Deforolimus: Phase II started

Ariad began a double-blind, placebo-controlled, international Phase II trial to evaluate oral deforolimus plus Casodex bicalutamide in about 150 patients. The trial start, which is expected to occur by the end...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >